MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid.
It is potent agonist of the CB1 receptor, and is sold online as a designer drug. Because of this, this drug has great binding affinity.
Pfizer invented it in 2008. it become one of the most potent cannabinoid agonists known in the market.
AB-CHMINACA is offered on the Internet either as ‘herbal mixtures’, as a powder, or in a liquid used in e-cigarette devices.
The primary route of administration to be inhalation. Smoking as herbal mixtures using vaping tubes gives you a great experience.
Reviews
There are no reviews yet.